TIGIT-induced NK cell depletion and the capacity to impede tumor progression by blocking TIGIT corroborate the assertion that the TIGIT-induced NK cell inhibitory axis is prominent in human cSCC (93). The gene discussed is TIGIT; the disease is neoplasm.